Techcyte

Techcyte is transforming the practice of pathology through a unified, AI-powered digital platform that streamlines complex workflows, integrates with core lab systems, and enhances communication across the lab. Built to reduce inefficiencies and diagnostic variability, Techcyte aims to help pathologists and lab professionals deliver faster, more consistent diagnoses.

By partnering with leading laboratories, scanner manufacturers, diagnostic hardware providers, and AI developers, together, we deliver a unified digital pathology and diagnostics platform to labs and clinics around the world, furthering our mission to positively impact the health of humans, animals, and the environment.

Techcyte Fusion Powers Unified Diagnostics for:
● Histology
● Surgical pathology
● Frozen section
● Parasitology
● Bacteriology
● Cervical Cytology
● Cytology
● AFB
● DigitalFISH
● Hematology

By combining advanced AI with seamless lab workflows, Fusion helps laboratories 
transition smoothly to digital pathology. Our platform supports remote collaboration, automation, and quantitative image analysis, enabling faster, more accurate diagnoses and 
better outcomes for patients.

Experience the future of pathology with Techcyte Fusion

Techcyte: Advancing Pathology Through Digital Transformation             

Founded in 2013, Techcyte is a global leader in AI-based digital pathology, serving clinical, anatomic, veterinary, and environmental laboratories across more than 40 countries. At the heart of its innovation is Techcyte Fusion™, a single platform that leverages artificial intelligence to digitize and optimize the entire diagnostic workflow.

With solutions supporting a wide range of pathology subspecialties, including histology 
parasitology, frozen section, bacteriology, and cervical cytology, Techcyte addresses key 
challenges facing laboratories today, such as workforce shortages, inter-operator variability, and the demand for faster, more scalable diagnostics. Fusion is designed for interoperability, integrating seamlessly with existing laboratory information systems (LIS) to streamline case management report sign-out.

Techcyte is actively engaged in advancing AI-assisted digital pathology through clinical 
validation, academic partnerships, and global collaborations. Notably, the company has 
collaborated with leading institutions to co-develop algorithms that are now used in
real-world laboratory settings. Techcyte’s CE-marked solutions are deployed in Europe, and 
the company is pursuing FDA clearance for U.S. applications.

Techcyte also supports a variety of scanner vendors to support both low- and high-throughput laboratories. Its proprietary technologies, including patented imaging enhancements for sparse samples, ensure quality digitization across various specimen types.

Through a robust network of global distribution partners and ongoing product innovation, 
Techcyte is helping laboratories modernize operations and prepare for the next generation 
of pathology.

For more information, visit www.techcyte.com.